March 11, 2013 at 16:00 PM EDT
Pharmathene Inc & Sequenom Inc. Gets FDA Alert (PIP, SQNM)
New York, NY -- (SBWIRE) -- 03/11/2013 -- Pharmathene Inc (NYSEAMEX:PIP) Develops treatments of diseases associated with biological warfare threats. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats. PhamAthene's product "Valortim" is a human monoclonal antibody designed to protect against inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here